Straits Times Index
3,332.80 -10.55 (-0.32%) S&P 500
5,460.48 -22.39 (-0.41%) Dow
39,118.86 -45.24 (-0.12%) Nasdaq
17,732.60 -126.10 (-0.71%) Bitcoin USD
61,657.78 +747.48 (+1.23%) CMC Crypto 200
1,279.97 -3.86 (-0.30%)
BioLineRx Ltd. (YP2A.F)
| Previous close | 0.4740 |
| Open | 0.4840 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.4840 - 0.4840 |
| 52-week range | 0.4740 - 2.3800 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 42.545M |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript
BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript March 26, 2024 BioLineRx Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Fourth Quarter and Full Year 2023 Financial […]
- Insider Monkey
BioLineRx Ltd. (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript
BioLineRx Ltd. (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript November 20, 2023 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Third Quarter 2023 Financial Results Conference Call. All participants are presently in a listen-only mode. Following management’s formal presentation, instructions will be given for the question-and-answer session. [Operator Instructions] I would […]
